Cargando…
Novel Activity of ODZ10117, a STAT3 Inhibitor, for Regulation of NLRP3 Inflammasome Activation
The NLRP3 inflammasome serves as a host defense mechanism against various pathogens, but there is growing evidence linking its activation in sterile condition to diverse inflammatory diseases. Therefore, the identification of specific inhibitors that target NLRP3 inflammasome activation is meaningfu...
Autores principales: | Kang, Ju-Hui, Lee, Se-Bin, Seok, Jiu, Kim, Dong-Hyuk, Ma, Gaeun, Park, Jooho, Jeong, Ae Jin, Ye, Sang-Kyu, Kang, Tae-Bong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094431/ https://www.ncbi.nlm.nih.gov/pubmed/37047051 http://dx.doi.org/10.3390/ijms24076079 |
Ejemplares similares
-
Development of Oxadiazole-Based ODZ10117 as a Small-Molecule Inhibitor of STAT3 for Targeted Cancer Therapy
por: Kim, Byung-Hak, et al.
Publicado: (2019) -
STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model
por: Kim, Byung-Hak, et al.
Publicado: (2020) -
NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation
por: Akther, Mahbuba, et al.
Publicado: (2021) -
BOT-4-one attenuates NLRP3 inflammasome activation: NLRP3 alkylation leading to the regulation of its ATPase activity and ubiquitination
por: Shim, Do-Wan, et al.
Publicado: (2017) -
Anti-Inflammatory Effect ofEmodin via Attenuation of NLRP3 Inflammasome Activation
por: Han, Ji-Won, et al.
Publicado: (2015)